Abrogated cardioprotective effect of ischemic preconditioning in ovariectomized rat heart

Human and Experimental Toxicology

Volumn 35, Issue 6, 2016, Pages 644-653

  Goyal, A ^a   Semwal, B C ^a   Yadav, H N ^a  

^a GLA UNIVERSITY   (India)

Author keywords

caveolin; daidzein; ischemic preconditioning; nitric oxide; Ovariectomy

Indexed keywords

CREATINE KINASE MB; DAIDZEIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLIBENCLAMIDE; LACTATE DEHYDROGENASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRITE; TRIPHENYLTETRAZOLIUM; CAVEOLIN 1; ISOFLAVONE DERIVATIVE; PHYTOESTROGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENZYME RELEASE; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE INJURY; HEART PROTECTION; ISCHEMIC PRECONDITIONING; ISOLATED HEART; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; ANIMAL; ANTAGONISTS AND INHIBITORS; DISEASE MODEL; DRUG EFFECTS; FEMALE; HEART; HEART INFARCTION PREVENTION; IN VITRO STUDY; METABOLISM; MYOCARDIAL INFARCTION; PHYSIOLOGY; WISTAR RAT;

ANIMALS; CAVEOLIN 1; CREATINE KINASE, MB FORM; DISEASE MODELS, ANIMAL; FEMALE; HEART; IN VITRO TECHNIQUES; ISCHEMIC PRECONDITIONING, MYOCARDIAL; ISOFLAVONES; L-LACTATE DEHYDROGENASE; MYOCARDIAL INFARCTION; NITRITES; OVARIECTOMY; PHYTOESTROGENS; RATS, WISTAR;

EID: 84971278861     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327115597980     Document Type: Article

References (56)

1. Barrett-Connor E,. Sex differences in coronary heart disease: why are women so superior? The 1995 ancel keys lecture. Circulation 1997; 95: 252-264.
2. Clarkson TB, Cline JM, Williams JK, et al.Gonadal hormone substitutes: effects on cardiovascular system. Osteoporosis Int 1997; 1: S43-S51.
3. Bernard JG, Karen S, Bongani MM, et al.The epidemic of cardiovascular disease in the developing world: global implications. Eur Heart J 2010; 31: 642-648.
4. Vandormael M, Grines CL, George BS, et al.The thrombolysis and angioplasty in myocardial infarction: a randomized trial of late reperfusion therapy for acute myocardial infarction. Circulation 1992; 85: 2090-2099.
5. Kloner RA,. Does reperfusion injury exist in humans?. J Am Coll Cardio 1993; 21: 537-545.
6. Collard CD, Gelman S,. Pathophysiology, clinical manifestation and prevention of ischemia reperfusion injury. Anesthesiology 2001; 94: 1133-1138.
7. Murry CE, Jennings RB, Reimer KA,. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124-1136.
8. Stokoe D, Stephens LR, Copeland T, et al.Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B. Science 1997; 277: 567-570.
9. Garg K, Yadav HN, Singh M, et al.Mechanism of cardioprotective effect of erythropoietin-induced preconditioning in rat heart. Indian J Pharmacol 2010; 42: 219-223.
10. Ferdinandy P, Schulz R, Baxter GF,. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning and postconditioning. Pharmacol Rev 2007; 59: 418-458.
11. Prendes MGM, Gonzalez M, Savino EA, et al.Role of endogenous nitric oxide in classic preconditioning in rat hearts. Regul Pept 2007; 139: 141-145.
12. Snoeckx LH, Van Der Vuesse GJ, Coumans WA, et al.Differences in ischaemia tolerance between hypertrophied hearts of adult and aged spontaneously hypertensive rats. Cardiovasc Res 1996; 27: 874-881.
13. Snoeckx LH, Van Der Vusse GJ, Coumans WA, et al.Myocardial function in normal and spontaneously hypertensive rats during reperfusion after a period of global ischemia. Cardiovasc Res 1986; 20: 67-75.
14. Yadav HN, Singh M, Sharma PL,. Involvement of GSK-3β in attenuation of cardioprotective effect of ischemic preconditioning in diabetic rat heart. Mol Cell Biochem 2010; 343: 75-81.
15. Ajmani P, Yadav HN, Singh M, et al.Involvement of caveolin in attenuation of cardioprotective effect of ischemic preconditioning in diabetic rat heart. BMC Cardiovasc Disord 2011; 11: 43.
16. Yadav HN, Singh M, Sharma PL,. Modulation of cardioprotective effect of ischemic preconditioning in hyperlipidaemic rat heart. Eur J Pharmacol 2010; 643: 78-83.
17. Abete P, Ferrara N, Cioppa A, et al.Preconditioning does not prevent postischemic dysfunction in aging heart. J Am Coll Cardiol 1996; 27: 1777-1786.
18. Ferdinandy P, Szilvassy Z, Baxter GF,. Adaptation to myocardial stress in disease states: is preconditioning a healthy heart phenomenon? Trends Pharmacol Sci 1998; 19: 223-229.
19. Palade G,. Fine structure of blood capillaries. J Appl Physiol 1953; 24: 1424-1436.
20. Minshall RD, Tiruppathi C, Vogels SM, et al.Vesicle formation and traffickng in endothelial cells and regulation of endothelial barrier function. Histochem Cell Biol 2002; 117: 105.
21. Feron O, Balligand JL,. Caveolin and the regulation of endothelial nitric oxide synthase in the heart. Cardiovasc Res 2006; 69: 788-797.
22. Koneru S, Penumathsa SV, Thirunavukkarasu M, et al.Redox regulation of ischemic preconditioning is mediated by the differential activation of caveolins and their association with eNOS and glut-4. Am J Physiol, Heart Cir Physiol 2007; 292: 2060-2072.
23. ATP. Am J Physiol 2008; 295: H953-H961.
24. Garcia-Carden G, Martasek P, Masters BSS, et al.Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the NOS caveolin binding domain in vivo. J Biol Chem 1997; 272: 25437-25440.
25. Maniatis NA, Brovkovych V, Allen SE, et al.Novel mechanism of endothelial nitric oxide synthase activation mediated by caveolae internalization in endothelial cells. Circ Res 2006; 99: 870-877.
26. Garlid KD, Costa ADT, Quinlan CL, et al.Cardioprotective signalling to mitochondria. J Mol Cell Cardiol 2009; 46: 858-866.
27. Pelligrino DA, Ye S, Tan F, et al.NO-dependent piol reticular dialation in the female rat: effects of chemic estrogen depletion and repletion. Biochem Biophys Res Commun 2000; 269: 165.
28. Woodman OL, Missen MA, Boujaoude M,. Diadzein and 17beta-estradiol enhance nitric oxide synthase activity associated with an increase in calmodulin and a decrease in caveolin-1. J Cardiovasc Pharm 2004; 44: 155-163.
29. Hishikawa K, Nakaki T, Marumo T, et al.Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells. FEBS Letters 1995; 360: 291.
30. 2+ calmodulin and caveolin. J Biol Chem 1997; 272: 15583.
31. Camper-Kirby D, Welch S, Walker A, et al.Myocardial Akt activation and gender: increased nuclear activity in females versus males. Circ Res 2001; 88: 1020-1027.
32. Fulton D, Gratton JP, McCabe TJ, et al.Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 1999; 399: 597-601.
33. Dimmeler S, Fleming I, Fisslthaler B, et al.Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999; 399: 601-605.
34. McCabe TJ, Fulton D, Roman LJ, et al.Enhanced electron flux and reduced calmodulin dissociation may explain "calcium-independent" eNOS activation by phosphorylation. J Biol Chem 2000; 275: 6123-6128.
35. Langendorff O,. Untersuchungen am uberlebenden saugethierherzen. Pflugers Arch Ges Physiol Mensch Tiere 1895; 61: 291-332.
36. Skrzypiec-Spring M, Grotthus B, Szeläg A, et al.Isolated heart perfusion according to langendorff-still viable in the new millennium. J Pharmacol Toxicol Methods 2007; 55: 113-126.
37. Fishbein MC, Meerbaum S, Rit J, et al.Early phase acute myocardial infarct size quantification: validation of the triphenyltetrazolium chloride tissue enzyme staining technique. Am Heart J 1981; 101: 593-600.
38. Nachlas M, Schnitka C,. Macroscopic identification of early myocardial infarcts by alterations in dehydrogenase activity. Am J Pathol 1963; 42: 379-406.
39. Klein HH, Pushman S, Schaper J, et al.The mechanism of the tetrazolium reaction in identifying experimental infarction. Eur Soc Pathol, Virchows Archiv 1981; 393: 287-297.
40. Chopra K, Singh M, Kaul N, et al.Decrease of myocardial infarct size with desferroxamine: possible role of oxygen free radicals in its ameliorative effect. Mol Cell Biochem 1992; 13: 71-76.
41. Marletta MA, Yoon PS, Iyenger R, et al.Macrophageoxidation of l -arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochem 1988; 27: 8706-8711.
42. Szabo C, Thiemermann C, Vane JR,. Dihydropyridine modulators of calcium channel inhibit the induction of nitric oxide synthase by endotoxin in cultured J774.2 cells. Biochem Biophys Res Commun 1993; 196: 825-830.
43. Szabo C, Wu CC, Mitchell JA, et al.Platelet activating factor contributes to the induction of nitric oxide synthase by bacterial lipopolysaccharide. Circ Res 1993; 73: 991-999.
44. Williams TM, Lisanti MP,. The caveolin genes: from cell biology to medicine. Ann Med 2004; 36: 584-595.
45. Shaul PW, Anderson RGW,. Role of plasmalemmal caveolae in signal transduction. Am J Physiol 1998; 275: L843-L851.
46. Patel HH, Murray F, Insel PA,. Caveolae as organizers of pharmacologically relevant signal transduction molecules. Annu Rev Pharmacol Toxicol 2007; 48: 359-391.
47. Lisanti MP, Scherer P, Tang ZL, et al.Caveolae, caveolin and caveolin-rich membrane domains: a signaling hypothesis. Trends Cell Biol 1994; 4: 231-235.
48. Couet J, Sargiacomo M, Lisanti MP,. Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J Biol Chem 1997; 272: 30429-30438.
49. Song KS, Sargiacomo M, Galbiati F, et al.Targeting of subunit and c-Src tyrosine kinase to caveolae membranes: clarifying the role of N-myristoylation. Cell Mol Biol 1997; 43: 293-303.
50. Feron O, Belhassen L, Kobzik L, et al.Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J Biol Chem 1996; 271: 22810-22814.
51. " phosphorylation. Cardiovasc Res 2008; 79: 387-394.
52. Sharma S, Singh M, Sharma PL,. Ameliorative effect of daidzein: a caveolin-1 inhibitor in endothelium dysfunction induced by ovariectomy. Indian J Exp Biol 2012; 50: 28-34.
53. Sobey GC, Weiler MJ, Boujaoude M, et al.Effect of short-term phytoestrogen treatment in male rats on nitric oxide mediated responses of carotid and cerebral arteries: comparison with 17-β estradiol. J Pharmacol Exp Ther 2004; 310: 135-140.
54. ATP channels in cardioprotective effect of remote aortic preconditioning in isolated rat heart. J Cardiovasc Dis Res 2010; 1: 145-151.
55. ATP channels. J Cardiovasc Electr 1999; 10: 741-754.
56. Murphy E,. Primary and secondary signalling pathways in early preconditioning that converge on the mitochondria to produce cardioprotection. Circ Res 2004; 94: 7-16.